• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Data Brief. The Data set for Patient Information Based Algorithm to Predict Mortality Cause by COVID-19

tetano

Editor, Senior Moderator
Data Brief. 2020 Apr 24:105619. doi: 10.1016/j.dib.2020.105619. [Epub ahead of print]
The Data set for Patient Information Based Algorithm to Predict Mortality Cause by COVID-19.


Li J[SUP]1[/SUP], Wang L[SUP]1,[/SUP][SUP]2[/SUP], Guo S[SUP]3[/SUP], Xie N[SUP]4[/SUP], Yao L[SUP]5,[/SUP][SUP]6[/SUP], Cao Y[SUP]6[/SUP], Day SW[SUP]7[/SUP], Howard SC[SUP]7[/SUP], Graff JC[SUP]7[/SUP], Gu T[SUP]8[/SUP], Ji J[SUP]9[/SUP], Gu W[SUP]1,[/SUP][SUP]10[/SUP], Sun D[SUP]6[/SUP].

Author information




Abstract

The data of COVID-19 disease in China and then in South Korea were collected daily from several different official websites. The collected data included 33 death cases in Wuhan city of Hubei province during early outbreak as well as confirmed cases and death toll in some specific regions, which were chosen as representatives from the perspective of the coronavirus outbreak in China. Data were copied and pasted onto Excel spreadsheets to perform data analysis. A new methodology, Patient Information Based Algorithm (PIBA) [1], has been adapted to process the data and used to estimate the death rate of COVID-19 in real-time. Assumption is that the number of days from inpatients to death fall into a pattern of normal distribution and the scores in normal distribution can be obtained by observing 33 death cases and analysing the data [2]. We selected 5 scores in normal distribution of these durations as lagging days, which will be used in the following estimation of death rate. We calculated each death rate on accumulative confirmed cases with each lagging day from the current data and then weighted every death rate with its corresponding possibility to obtain the total death rate on each day. While the trendline of these death rate curves meet the curve of current ratio between accumulative death cases and confirmed cases at some points in the near future, we considered that these intersections are within the range of real death rates. Six tables were presented to illustrate the PIBA method using data from China and South Korea. One figure on estimated rate of infection and patients in serious condition and retrospective estimation of initially occurring time of CORID-19 based on PIBA.
? 2020 Published by Elsevier Inc.



KEYWORDS:

COVID-19; Coronavirus; Death Rate; Estimation; Normal distribution; PIBA; Prediction


PMID:32337324PMCID:PMC7180158DOI:10.1016/j.dib.2020.105619
 
Back
Top Bottom